This trial is testing two different medications to see which one works better at reversing muscle paralysis at the end of kidney transplant surgery, in order to reduce weakness and breathing problems after surgery.
1 Primary · 21 Secondary · Reporting Duration: Within up to 3 postoperative days and at 14 +/- 3 days after surgery
Active Control
Experimental Treatment
100 Total Participants · 2 Treatment Groups
Primary Treatment: Sugammadex · No Placebo Group · Phase 4
Age 18 - 90 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: